← Evidence map

TrialBritish journal of clinical pharmacology2022

Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects.

Wei Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34240455